HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ilinca Nicolae Selected Research

Interleukin-8 (Interleukin 8)

1/2016Interleukin 8 serum concentration, but not lactate dehydrogenase activity, positively correlates to CD34 antigen in melanoma tumors.
1/201525-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ilinca Nicolae Research Topics

Disease

9Neoplasms (Cancer)
01/2022 - 01/2011
7Melanoma (Melanoma, Malignant)
01/2020 - 01/2011
3Carcinogenesis
01/2022 - 01/2020
3Inflammation (Inflammations)
01/2020 - 07/2012
2Infections
12/2021 - 01/2017
2Neoplasm Metastasis (Metastasis)
10/2021 - 01/2016
2Lupus Nephritis
07/2021 - 06/2021
2Basal Cell Carcinoma (Rodent Ulcer)
01/2021 - 07/2012
2Dysplastic Nevus Syndrome (Dysplastic Nevus)
07/2015 - 01/2013
1Chronic Urticaria
07/2021
1IGA Glomerulonephritis (IGA Nephropathy)
06/2021
1Warts (Wart)
10/2019
1Lichen Planus (Lichen Ruber Planus)
10/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2019
1Squamous Cell Carcinoma of Head and Neck
01/2018
1Bacterial Infections (Bacterial Infection)
01/2017
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2016
1Pituitary Diseases (Disease, Anterior Pituitary)
07/2015
1Vitamin D Deficiency
01/2015
1Skin Neoplasms (Skin Cancer)
07/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2012

Drug/Important Bio-Agent (IBA)

5GangliosidesIBA
06/2021 - 01/2011
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2019
3Immunoglobulin M (IgM)IBA
06/2021 - 01/2013
3AntibodiesIBA
06/2021 - 01/2013
3Biomarkers (Surrogate Marker)IBA
10/2019 - 01/2015
2Oxidants (Oxidizing Agents)IBA
12/2021 - 10/2019
2AntioxidantsIBA
12/2021 - 10/2019
2theasinensin AIBA
10/2021 - 06/2021
2N-Acetylneuraminic Acid (Sialic Acid)IBA
10/2021 - 01/2016
2GlycoconjugatesIBA
10/2021 - 06/2021
2Sulfhydryl Compounds (Thiols)IBA
07/2021 - 07/2021
2Receptor for Advanced Glycation End ProductsIBA
07/2021 - 10/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 10/2019
2Immunoglobulin G (IgG)IBA
01/2020 - 01/2013
2Interleukin-8 (Interleukin 8)IBA
01/2016 - 01/2015
1Arginine (L-Arginine)FDA Link
12/2021
1DisulfidesIBA
07/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1AntigensIBA
01/2020
1Oncogene Proteins (Oncogene Protein)IBA
01/2020
16- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA
10/2019
1Fibrinogen (Factor I)FDA Link
10/2019
1purineIBA
02/2019
1Inflammation MediatorsIBA
01/2018
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2017
1CreatinineIBA
01/2016
1Urea (Carbamide)FDA LinkGeneric
01/2016
1Blood Glucose (Blood Sugar)IBA
01/2016
1CD34 Antigens (CD34 Antigen)IBA
01/2016
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2016
1ProlactinIBA
07/2015
1InterferonsIBA
07/2015
1VitaminsIBA
01/2015
1Vitamin DFDA LinkGeneric
01/2015
1G(M1) GangliosideIBA
01/2013
1C-Reactive ProteinIBA
07/2012
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2012
1lipid-associated sialic acid (LASA)IBA
01/2011

Therapy/Procedure

2Aftercare (After-Treatment)
07/2021 - 07/2015
2Therapeutics
07/2021 - 01/2011